Legal status in the United States
Is Linaclotide legal?
Read at FDA, DEA and WADAPublished by PepVault
Linaclotide is FDA-approved (Linzess, first in 2012), is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 18, 2026.
Linaclotide at a glance
| Check | Status, read Nov 18, 2026 |
|---|---|
| FDA approval | Approved (Linzess, 2012) |
| Compounding | Component of an approved drug (503A condition) |
| DEA schedule | Not controlled |
| Sport (WADA) | Not named on the list |
FDA approval
Linaclotide is FDA-approved as Linzess, a daily capsule, since 2012, and generic linaclotide is approved too.
Linzess (capsule)
Approved for irritable bowel syndrome with constipation (adults and children 7 and older), chronic constipation with no known cause in adults, and functional constipation in children 2 and older. NDA 202811, first approved August 30, 2012.
- Drugs@FDA: Linzess, application 202811, U.S. Food and Drug Administration. Read .
- Linzess prescribing information on DailyMed, National Library of Medicine (DailyMed). Read .
- Drugs@FDA: Linzess, application 202811, U.S. Food and Drug Administration. Read .
- Drugs@FDA data (openFDA): applications listing “LINACLOTIDE” as an active ingredient, U.S. Food and Drug Administration. Read .

Compounding
Linaclotide is the active ingredient of an FDA-approved drug (Linzess). FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name linaclotide.
The source: “Are components of FDA-approved drug products if an applicable USP or NF monograph does not exist”
- Bulk Drug Substances Used in Compounding (content current as of March 26, 2026), U.S. Food and Drug Administration. Read .
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026), U.S. Food and Drug Administration. Read .
- 503B Bulk Drug Substances List (content current as of May 16, 2024), U.S. Food and Drug Administration. Read .
DEA schedule
It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.
- 21 CFR Part 1308, Schedules of Controlled Substances (eCFR, up to date as of November 16, 2026), Electronic Code of Federal Regulations. Read .
- Controlled Substances, Alphabetical Order (dated November 17, 2026), Drug Enforcement Administration, Diversion Control Division. Read .
Sport (WADA)
The 2026 Prohibited List doesn’t name linaclotide, and S0, the class for unapproved substances, doesn’t reach an approved drug.
- World Anti-Doping Code International Standard, Prohibited List 2026 (in effect from January 1, 2026), World Anti-Doping Agency. Read .
What this means and doesn’t
This page reports what the agencies’ own pages said about Linaclotide in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.
It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.
Questions
Is Linaclotide FDA approved?
Linaclotide is FDA-approved as Linzess, a daily capsule, since 2012, and generic linaclotide is approved too.
Is Linaclotide a controlled substance?
It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.
Is Linaclotide banned in sport?
The 2026 Prohibited List doesn’t name linaclotide, and S0, the class for unapproved substances, doesn’t reach an approved drug.
What does FDA say about compounding Linaclotide?
Linaclotide is the active ingredient of an FDA-approved drug (Linzess). FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name linaclotide.